Evaluating a new drug designed to treat hyperlipidaemia (high levels of fats, including cholesterol, in the blood). The medication works by blocking a protein involved in regulating LDL (“bad”) cholesterol, with the aim of reducing cholesterol levels and lowering the risk of heart disease, heart attacks, and stroke.
In this study, we will assess how effectively the medication lowers LDL cholesterol and other blood lipids, while also evaluating its safety and how well it is tolerated by participants. Not actively recruiting
